| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/2007 | CN1296386C Use of CD 25 binding molecules in steroid-resistant patients |
| 01/24/2007 | CN1296380C Pharmaceutical compound |
| 01/24/2007 | CN1296379C Technique for preparing malonyl ginsenoside, and application of medication in treating diabetes |
| 01/24/2007 | CN1296378C CpG-N ODN gene sequence with high immunological activity CpG-S ODN and antagonism CpG-N ODN and use thereof |
| 01/24/2007 | CN1296375C Germanium caffeiate and its preparation technology |
| 01/24/2007 | CN1296369C Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| 01/24/2007 | CN1296368C Benzothiophenes as adenosine receptor regulating agent |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296361C Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/24/2007 | CN1296359C Novel heteroaryl derivatives and use thereof as pharmaceuticals |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296356C CCR-3 receptor antagonists VII |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296347C Compound of antitumor antibiotic of new carbon framework as well as preparation method and application |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296097C Polymer micelle medicine-carrying system |
| 01/24/2007 | CN1296094C Joint nutrient tablet |
| 01/24/2007 | CN1296091C Chinese traditional medicine composition for treating psoriasis |
| 01/24/2007 | CN1296084C Externally applied medicine for treating chronic dermatopathy |
| 01/24/2007 | CN1296063C Compound red sage preparation for treating cardiac and cerebral vascular diseases and its preparation process |
| 01/24/2007 | CN1296061C Health care food for preventing and treating heart cerebrovascular and cardiovascular disease and its preparation method |
| 01/24/2007 | CN1296060C Compound ginkgo leaf preparation and its making method |
| 01/24/2007 | CN1296058C Externally used ointment for treating burn and scald and preparation method thereof |
| 01/24/2007 | CN1296057C External applied liquid medicine for treating psoriasis |
| 01/24/2007 | CN1296056C Scar-free medicinal agent for burn |
| 01/24/2007 | CN1296055C Method for extracting bone calcium from animal bone powder |
| 01/24/2007 | CN1296053C Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 01/24/2007 | CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/24/2007 | CN1296051C New use of dextran sulfate |
| 01/24/2007 | CN1296050C Acarbose enteric coated tablets and its preparation method |
| 01/24/2007 | CN1296049C Sustained release preparation for treating cardiovascular diseases, and preparation method, quality control method |
| 01/24/2007 | CN1296048C Ginseng and ophiopogon saponin drops pills and their preparing method |
| 01/24/2007 | CN1296047C Caloporoside derivatives, methods for production thereof and their use |
| 01/24/2007 | CN1296046C Diltiazem hydrochloride control release capsule and its preparing method |
| 01/24/2007 | CN1296045C Dihydroergotoxine and its derivative oral disintegration tablet and its preparing process |
| 01/24/2007 | CN1296044C Freeze-dried preparation containing balofloxacin and its use |
| 01/24/2007 | CN1296043C Use of formula I Rapamycin compound in preparing pharmaceutical composition for treating solid tumor |
| 01/24/2007 | CN1296042C Acetyl salicyl sulfonone oral cavity disintegration tablet and its preparation method |
| 01/24/2007 | CN1296041C Active constituent of traditional Chinese medicine capable of inhibiting SARS coronavirus infection and its bioactivity measuring method |
| 01/24/2007 | CN1296040C Medicinal composition |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/24/2007 | CN1296038C External remedy for curing of vertebral body |
| 01/23/2007 | USRE39480 Chromium/biotin treatment of type II diabetes |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/23/2007 | US7166744 Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds |
| 01/23/2007 | US7166738 viricides; polymerase inhibitors; therapy for genetic engineered virus |
| 01/23/2007 | US7166733 Antitumor agents |
| 01/23/2007 | US7166730 Starting from a Corey aldehyde, i.e., 5-arylcarbonyloxycyclopenta[b]furan-2-one-4-carboxaldehyde; also crystalline 5-hydroxycyclopenta[b]furan-2-one and 2-ol derivatives 4-substituted with siloxyakyl groups as intermediates |
| 01/23/2007 | US7166729 Process for the preparation of 5-substituted isobenzofurans |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166725 Benzo[d]isoxazol-3-ol DAAO inhibitors |
| 01/23/2007 | US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water |
| 01/23/2007 | US7166721 Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166642 Use of cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 01/23/2007 | US7166641 Diclofenac salt of lidocaine |
| 01/23/2007 | US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/23/2007 | US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases |
| 01/23/2007 | US7166638 Statin derivatives |
| 01/23/2007 | US7166637 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
| 01/23/2007 | US7166636 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/23/2007 | US7166635 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 01/23/2007 | US7166634 Bis-indole pyrroles useful as antimicrobials agents |
| 01/23/2007 | US7166633 Method for synthesising perindopril and the pharmaceutically acceptable salt thereof |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166630 contains 4-[ alpha -hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid; prophylaxis, hypomyelination, dysmyelination or demyelination; myelin-associated glycoprotein (MAG) |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166628 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
| 01/23/2007 | US7166627 Antibiotic compositions and methods of using the same |
| 01/23/2007 | US7166626 Therapeutic treatment for sexual dysfunction |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
| 01/23/2007 | US7166624 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166619 Compounds for treatment of diseases associated with prenylation of proteins |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166616 Substituted alkanoic acids |
| 01/23/2007 | US7166615 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166612 Methods for reducing platelet activation platelet aggregaton or thrombosis |
| 01/23/2007 | US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 01/23/2007 | US7166610 Method of treating movement disorders using barbituric acid derivatives |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166606 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 01/23/2007 | US7166603 Dihydropyrimidone inhibitors of calcium channel function |
| 01/23/2007 | US7166602 Anticancer agents; antiinflammatory agents; antiarthritic agents; viricides; central nervous system disorders; Alzheimer's disease; cardiovascular disorders; fungicides |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166599 Trisubstituted pyrimidines |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/23/2007 | US7166595 3H-Pyrimidin-4-one derivatives; antiproliferative, anticarcinogenic and antiinflammatory agents; hyperplasia, restenosis, cardiac hypertrophy, autoimmune disorders; fungicides |